Abstract

BackgroundPrior to the antiretroviral (ARV) drug roll out in 2004, people living with HIV (PLHIV) in South Africa received disability grants when they were defined as "AIDS-sick". In the absence of available and effective medication, a diagnosis of AIDS portended disability. The disability grant is a critical component of South Africa's social security system, and plays an important role in addressing poverty among PLHIV. Given the prevalence of unemployment and poverty, disability grants ensure access to essential resources, like food, for PLHIV. Following the ARV roll out in South Africa, PLHIV experienced improved health that, in turn, affected their grant eligibility. Our aim is to explore whether PLHIV reduced or stopped treatment to remain eligible for the disability grant from the perspectives of both PLHIV and their doctors.MethodsA mixed-methods design with concurrent triangulation was applied. We conducted: (1) in-depth semi-structured interviews with 29 PLHIV; (2) in-depth semi-structured interviews with eight medical doctors working in the public sector throughout the Cape Peninsula; (3) three focus group discussions with programme managers, stakeholders and community workers; and (4) a panel survey of 216 PLHIV receiving ARVs.ResultsUnemployment and poverty were the primary concerns for PLHIV and the disability grant was viewed as a temporary way out of this vicious cycle. Although loss of the disability grant significantly affected the well-being of PLHIV, they did not discontinue ARVs. However, in a number of subtle ways, PLHIV "tipped the scales" to lower the CD4 count without stopping ARVs completely. Grant criteria were deemed ad hoc, and doctors struggled to balance economic and physical welfare when assessing eligibility.ConclusionsIt is crucial to provide sustainable economic support in conjunction with ARVs in order to make "positive living" a reality for PLHIV. A chronic illness grant, a basic income grant or an unemployment grant could provide viable alternatives when the PLHIV are no longer eligible for a disability grant.

Highlights

  • Prior to the antiretroviral (ARV) drug roll out in 2004, people living with HIV (PLHIV) in South Africa received disability grants when they were defined as “AIDS-sick”

  • Ramifications of the disability grant for PLHIV employment was desired by the HIV-positive participants, it was a reality for very few

  • Given that the South African social welfare system places the responsibility for determining disability grant eligibility on doctors, our findings indicate that doctors experience considerable pressure when recommending eligibility, so that they use different kinds of criteria to determine eligibility

Read more

Summary

Introduction

Prior to the antiretroviral (ARV) drug roll out in 2004, people living with HIV (PLHIV) in South Africa received disability grants when they were defined as “AIDS-sick”. The disability grant is a critical component of South Africa’s social security system, and plays an important role in addressing poverty among PLHIV. Following the ARV roll out in South Africa, PLHIV experienced improved health that, in turn, affected their grant eligibility. HIV prevalence is highest among South Africa’s majority black African population, which has the highest rate of unemployment and the lowest per capita income of all the racial groups [2,3]. The roll out of antiretrovirals (ARVs) in the public health system started in 2004 in South Africa and followed a hard political struggle [4,5,6]. South Africa’s welfare de Paoli et al Journal of the International AIDS Society 2012, 15:6 http://www.jiasociety.org/content/15/1/6 system is based on the premise of full employment with no support system for the unemployed

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call